Albert D. Mason Inc’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
17,193
+22
+0.1% +$2K 0.93% 33
2026
Q1
$1.65M Buy
17,171
+150
+0.9% +$15K 1.07% 32
2025
Q4
$1.66M Hold
17,021
1.09% 30
2025
Q3
$1.21M Buy
17,021
+898
+6% +$59.8K 0.79% 55
2025
Q2
$964K Sell
16,123
-1,146
-7% -$62.8K 0.7% 60
2025
Q1
$906K Buy
17,269
+333
+2% +$18.7K 0.62% 66
2024
Q4
$931K Buy
16,936
+2,277
+16% +$120K 0.62% 68
2024
Q3
$737K Buy
+14,659
New +$676K 0.47% 83

Other funds holding IRMD

Albert D. Mason Inc's IRMD Position: Q2 2026 in Review

Albert D. Mason Inc increased its iRadimed (IRMD) stake by 0.13% in Q2 2026, buying an estimated $2K and bringing the position to 17,193 shares worth $1.64M. The position accounts for 0.93% of the portfolio, ranked #33.

Albert D. Mason Inc first reported a position in IRMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.66M in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Albert D. Mason Inc held 17,193 shares of iRadimed worth $1.64M as of Q2 2026.
  • Albert D. Mason Inc bought 22 iRadimed shares in Q2 2026, an estimated $2K.
  • iRadimed made up 0.93% of Albert D. Mason Inc's portfolio in Q2 2026, its #33 holding.
  • Albert D. Mason Inc first reported a position in iRadimed in Q3 2024 and has held it in 8 quarters since.
  • Albert D. Mason Inc's iRadimed position peaked at $1.66M in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Albert D. Mason Inc's 13F filing for Q2 2026, filed 22 Jul 2026.